Taking Mounjaro for the First Time: What the Evidence Actually Says

What the trial data tells us about the first weeks

The SURMOUNT-1 trial, published in the New England Journal of Medicine, started all participants on 2.5 mg tirzepatide once weekly. That dose was never expected to drive significant weight change on its own. Its purpose, documented in the study protocol and reflected in the Mounjaro summary of product characteristics, is to reduce early gastrointestinal discomfort while the body adapts to the medicine. Prescribers typically review tolerability after four weeks before moving to the next strength.

What that means practically: don't measure the medicine's effectiveness by how you feel in week one. Appetite changes are subtle at first. Some people notice a modest reduction in hunger within the first fortnight; others don't feel much at all until a higher dose is reached. Both are normal. The trial's impressive average weight reductions built gradually across 72 weeks, they were not front-loaded.

If you want to read more about what the first few days on Mounjaro feel like day by day, that page goes into considerably more detail on the early adjustment period.

The side effects that appear earliest, and what usually helps

The most commonly reported side effects in the first weeks are gastrointestinal: nausea is the most frequent, followed by constipation, loose stools, indigestion and burping. The NHS's tirzepatide page lists these alongside less common effects including fatigue, headache and dizziness. For most people, nausea peaks in the day or two after injection, then fades. Eating smaller portions, avoiding very fatty or rich meals, and staying well hydrated all make a difference, not because those habits are required, but because gastric emptying is already slower on tirzepatide and heavy meals compound the effect.

A question our prescribers hear most weeks: "should I take my first injection on a specific day?" There is no clinically mandated day, but choosing a day when you can rest the following morning (a Friday evening, for instance) means any nausea peaks before a working day. It is worth picking a consistent day of the week, because the once-weekly schedule is easiest to maintain when it anchors to a routine.

Injection site reactions (mild redness or itching at the injection point) are also possible early on. Rotating between the abdomen, thigh and upper arm, and using a fresh needle each time, reduces their frequency. For practical guidance on technique, this walkthrough of using Mounjaro for the first time covers the injection steps in detail.

One symptom that should never wait: severe, persistent stomach pain that radiates towards the back, with or without vomiting, needs urgent medical attention. It is a potential sign of pancreatitis, an uncommon but serious side effect that the MHRA highlighted in a safety update in January 2026. Report any suspected side effects through the Yellow Card scheme.

Injection technique on day one

The Mounjaro KwikPen is a pre-filled device; each pen contains four weekly doses. Before your first injection, the pen should have been stored in the fridge at 2–8°C. Remove it around 30 minutes before you intend to inject, so it reaches room temperature, cold medicine at the injection site is a common, easily avoided cause of discomfort. The exact room-temperature window for storage is set out in the patient information leaflet; always follow that, not general advice online.

Pinch the skin at your chosen site, insert the needle at a 90-degree angle, press the plunger fully until the dose indicator window confirms delivery, and hold for a few seconds before withdrawing. There is more on the practical routine (including what to do if you're unsure the full dose went in) on the first day on Mounjaro page.

Storage, disposal and travel questions come up frequently. A dedicated tips page addresses common logistics, including how to handle the pen if you travel or your fridge is temporarily unavailable.

What taking Mounjaro looks like over the months ahead

Starting tirzepatide is the beginning of a titration journey, not a one-and-done prescription. Dose increases happen roughly every four weeks, guided by your prescriber, based on how well you are tolerating the current dose. Rushing that process isn't possible through a regulated service, and for good reason. The evidence for significant weight reduction comes from the higher doses reached over months, not the starting pen.

Alongside the medicine, the licence requires a reduced-calorie diet and increased physical activity. That framing matters: tirzepatide reduces appetite and slows gastric emptying, which makes eating less feel far more manageable. Many people find this the point at which behaviour change finally becomes sustainable rather than effortful. Protein intake deserves particular attention, appetite suppression can mean total food intake drops sharply, and adequate protein helps preserve lean muscle mass during weight loss.

Private treatment costs are a practical consideration worth understanding early. A breakdown of what Mounjaro costs privately, and what different price points do and don't include, is on the Mounjaro cost page. Treatment through a regulated service includes clinical oversight at every step, that oversight is part of what you are paying for, and it matters most at the beginning, when questions are most frequent.

If you want a broader overview of tirzepatide (mechanism, licensing, trial results and NHS access) the tirzepatide overview covers the full picture. And if you are ready to discuss whether Mounjaro is suitable for your circumstances, start a free consultation with our prescribers.